61
Participants
Start Date
January 17, 2017
Primary Completion Date
October 6, 2022
Study Completion Date
October 6, 2022
Immediate Release (IR) Formulation
Immediate Release (IR) Formulation
Gastro-Retentive (GR) Formulation
Gastro-Retentive (GR) Formulation
Dexamethasone
Dexamethasone
Pomalidomide
Pomalidomide
Research Site, Clayton
Research Site, Perth
Research Site, Murdoch
Research Site, New York
Research Site, Bethesda
Research Site, Charlotte
Research Site, Atlanta
Research Site, Pamplona
Research Site, Tampa
Research Site, Salamanca
Research Site, Cleveland
Research Site, Canton
Research Site, Milwaukee
Research Site, St Louis
Research Site, San Antonio
Research Site, West Hollywood
Research Site, Chicago
Research Site, Hackensack
Research Site, Calgary
Research Site, Toronto
Lead Sponsor
Amgen
INDUSTRY